Klára Gadó

438 citations
30 papers · 313 indexed · h-index 9
Topics
Multiple Myeloma Research and Treatments (6 papers)Blood Coagulation and Thrombosis Mechanisms (3 papers)Heparin-Induced Thrombocytopenia and Thrombosis (2 papers)

In The Last Decade

Klára Gadó

24 papers receiving 301 citations

Peers

Klára Gadó
Comparison fields: 5 of 86
  • Hematology 106
  • Molecular Biology 102
  • Oncology 88
  • Immunology 62
  • Physiology 34
Replace Han Zhu with:
Han Zhu China
Elizabeth Jordan United States
Elizabeth A. McCart United States
Arash Rafii Tabrizi United States
Honglei Wang China
Habib Haybar Iran
Maribel Tírado-Gómez United States
Kanyalakshmi Ayyanar United States
Shubhada Jagasia United States
Takuji Miyoshi Japan
Klára Gadó relative to Han Zhu China Han Zhu's profile →
Citations per field
00.5×3.3×
Han Zhu · 1×
Citations per year

Countries citing papers authored by Klára Gadó

Since Specialization
Citations

This map shows the geographic impact of Klára Gadó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klára Gadó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klára Gadó more than expected).

Fields of papers citing papers by Klára Gadó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klára Gadó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klára Gadó. The network helps show where Klára Gadó may publish in the future.

Co-authorship network of co-authors of Klára Gadó

This figure shows the co-authorship network connecting the top 25 collaborators of Klára Gadó. A scholar is included among the top collaborators of Klára Gadó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klára Gadó. Klára Gadó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 14
6 1
7 1
8 2
9 3
10 5
11 2
12 17
13 3
14 11
15 9
16
Mouse plasmacytoma: an experimental model of human multiple myeloma.
48
17 123
18 27
19 0
20 1

About Klára Gadó

Klára Gadó is a scholar working on Hematology, Health Informatics and Internal Medicine, having authored 30 papers that have together received 313 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). The work is most often cited by research in Hematology (106 citations), Oncology (88 citations) and Immunology (62 citations). Klára Gadó has collaborated with scholars based in Hungary, United States and Antigua and Barbuda. Frequent co-authors include Gyula Domján, András Falus, Hargita Hegyesi, Gábor Gigler, Katalin Pálóczi, Gabriella Dörnyei, Béla Tóth, György M. Nagy, András Szabó and Zoltán Zsolt Nagy. Their work appears in journals such as Inflammation Research, Immunology Letters and Cell Biology International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026